• español
    • English
    • português
  • English 
    • español
    • English
    • português
  • Login
Search 
  •   Home
  • Productos de Investigación - Creación
  • Search
  •   Home
  • Productos de Investigación - Creación
  • Search
JavaScript is disabled for your browser. Some features of this site may not work without it.
RecursosRecursos de apoyo¿Cómo publicar?

Browse

All of ExpeditioCommunities & CollectionsBy Issue DateAuthorsTitlesSubjects
This CommunityBy Issue DateAuthorsTitlesSubjects

My Account

LoginRegister

Discover

AuthorHuang, Ian (2)Pranata, Raymond (2)Wang, Dee Dee (2)Zervos, Marcus (2)Al-Farabi, Makhyan Jibril (1)Alangaden, George J. (1)Alblooshi, Rehab M. (1)Alexia, Bertuzzi (1)Aljurf, Mahmoud (1)Allu, Prasanna K.R. (1)... View MoreSubjectCoronavirus (34)COVID-19 (34)
Mortality (34)
SARS-CoV-2 (34)
Síndrome respiratorio agudo grave (34)
Pandemic (4)Hydroxychloroquine (3)Patients (3)Antiviral (2)Cancer (2)... View MoreHas File(s)Yes (27)No (7)
Estadísticas GTMVer Estadísticas GTM

Search

Show Advanced FiltersHide Advanced Filters

Filters

Use filters to refine the search results.

Now showing items 11-20 of 34

  • Sort Options:
  • Relevance
  • Title Asc
  • Title Desc
  • Issue Date Asc
  • Issue Date Desc
  • Results Per Page:
  • 5
  • 10
  • 20
  • 40
  • 60
  • 80
  • 100
Thumbnail

A call for strengthened evidence on targeted, non-pharmaceutical interventions against COVID-19 for the protection of vulnerable individuals in sub-Saharan Africa 

Colebunders, Robert; Siewe Fodjo, Joseph Nelson; Vanham, Guido; Van den Bergh, Rafael
Following the easing of lockdown measures in many sub-Saharan African countries, coronavirus disease 2019 (COVID-19) cases have been on the rise. As the transmission of severe acute respiratory syndrome coronavirus 2 ...
Thumbnail

Socioeconomic inequality in global incidence and mortality rates from COVID-19: an Ecological study 

Shahbazi, Fatemeh; Khazaei, Salman
Objective: Coronavirus disease is an infectious disease caused by a newly discovered coronavirus. Epidemiological and clinical features of patients with COVID-19 have been examined but Socio-economic aspects of the issue ...
Thumbnail

Hypotheses about sub-optimal hydration in the weeks before coronavirus dis‐ ease (COVID-19) as a risk factor for dying from COVID-19 

Stookey, Jodi D.; Allu, Prasanna K.R.; Chabas, Dorothee; Pearce, David; Lang, Florian
To address urgent need for strategies to limit mortality from coronavirus disease 2019 (COVID-19), this review describes experimental, clinical and epidemiological evidence that suggests that chronic sub-optimal hydration ...
Thumbnail

The risk and prognosis of COVID-19 infection in cancer patients: A systematic review and meta-analysis 

ElGohary, Ghada M.; Hashmi, Shahrukh; Styczynski, Jan; Kharfan-Dabaja, Mohamed A.; Alblooshi, Rehab M.; Cámara, Rafael de la; Mohmed, Sherif; Alshaibani, Alfadel; Cesaro, Simone; El-Aziz, Nashwa Abd; Almaghrabi, Reem; Gergis, Usama; Majhail, Navneet S.; EL-Gohary, Yasser; Chemaly, Roy F.; Aljurf, Mahmoud; El Fakih, Riad
Numerous studies have been published regarding outcomes of cancer patients infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus causing the coronavirus disease 2019 (COVID-19) infection. ...
Thumbnail

Hypokalemia as a sensitive biomarker of disease severity and invasive mechanical ventilation requirement in COVID-19 pneumonia: a case series of 306 Mediterranean patients 

Oscar Moreno-Perez; Leon-Ramirez, Jose-Manuel; Fuertes-Kenneally, Laura; Perdiguero, Miguel; Andres, Mariano; Garcia-Navarro, Mar; Ruiz-Torregrosa, Paloma; Gil, Joan; Boix, Vicente; Gil, Joan; Merino, Esperanza
Objectives Serum levels of potassium (K+) seem significantly lower in severe SARS-CoV2 infection, with an unknown clinical translation. The objective was to investigate whether hypokalemia acts as a biomarker of severity ...
Thumbnail

Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19 

Arshad, Samia; Kilgore, Paul; Chaudhry, Zohra S.; Jacobsen, Gordon; Wang, Dee Dee; Huitsing, Kylie; Brar, Indira; Alangaden, George J.; Ramesh, Mayur S.; McKinnon, John E.; O’Neill, William; Zervos, Marcus; Ford, Henry
Significance: The United States is in an acceleration phase of the COVID-19 pandemic. Currently there is no known effective therapy or vaccine for treatment of SARS-CoV-2, highlighting urgency around identifying effective ...
Thumbnail

Reckoning with mortality: global health, HIV, and the politics of data 

Kavanagh, Matthew M; Katz, Ingrid T; Holmes, Charles B
liminating unnecessary deaths is at the core of global health efforts, from responses to COVID-19 to HIV, non-communicable diseases, and maternal mortality. However, experience with HIV shows that reducing mortality ...
Thumbnail

Pathophysiological basis and rationale for early outpatient treatment of SARS-CoV-2 (COVID-19) Infection 

McCullough, Peter A.; Kelly, Ronan J.; Ruocco, Gaetano; Lerma, Edgar; Tumlin, James; Wheelan, Kevin; Katz, Nevin; Lepor, Norman E.; Vijay, Kris; Carter, Harvey; Singh, Bhupinder; McCullough, Sean P.; Bhambi, Brijesh K.; Palazzuoli, Alberto; De Ferrar, Gaetano M; Milligan, Gregory; Safder, Taimur; Tecson, Kristen M.; Wang, Dee Dee; McKinnon; O’Neill, William W.; Zervos, Marcus; Risch, Harvey A.
Approximately 9 months of the SARS-CoV-2 virus spreading across the globe has led to widespread COVID-19 acute hospitalizations and death. The rapidity and highly communicable nature of the SARS-CoV-2 outbreak has hampered ...
Thumbnail

Unhappiness and age 

Blanchflower, David G
Thumbnail

Associations of procalcitonin, C‐reaction protein and neutrophil‐to‐lymphocyte ratio with mortality in hospitalized COVID‐19 patients in China 

Xu, Jian‑bo; Xu, Chao; Zhang, Ru‑bing; Wu, Meng; Pan, Chang‑kun; L, Xiu‑jie; Wang, Qian; Zeng, Fang‑fang; Zhu, Sui
Coronavirus disease 2019 (COVID-19) is an important and urgent threat to global health. Infammation factors are important for COVID-19 mortality, and we aim to explore whether the baseline levels of procalcitonin (PCT), ...
  • 1
  • 2
  • 3
  • 4

Carrera 4 # 22-61 Teléfono: (+57 1) 242 7030 - 018000111022 Fax: (+57 1) 561 2107 Bogotá D.C., Colombia

Fundación Universitaria de Bogotá Jorge Tadeo Lozano | Vigilada Mineducación

Institución de educación superior privada, de utilidad común, sin ánimo de lucro y su carácter académico es el de Universidad.

Reconocimiento personería jurídica: Resolución 2613 del 14 de agosto de 1959 Minjusticia.

Institución de Educación Superior sujeta a inspección y vigilancia por el Ministerio de Educación Nacional.

 

Términos y condiciones | Políticas

 

 


Carrera 4 # 22-61 Teléfono: (+57 1) 242 7030 - 018000111022 Fax: (+57 1) 561 2107 Bogotá D.C., Colombia

Fundación Universitaria de Bogotá Jorge Tadeo Lozano | Vigilada Mineducación

Institución de educación superior privada, de utilidad común, sin ánimo de lucro y su carácter académico es el de Universidad.

Reconocimiento personería jurídica: Resolución 2613 del 14 de agosto de 1959 Minjusticia.

Institución de Educación Superior sujeta a inspección y vigilancia por el Ministerio de Educación Nacional.

 

Términos y condiciones | Políticas